| 证券代码：002157 | 证券简称：*ST 正邦 | 公告编号：2023—128 | | --- | --- | --- | | 转债代码：128114 | 转债简称：正邦转债 | | 江西正邦科技股份有限公司 关于公司股票可能被终止上市的风险提示公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、江西正邦科技股份有限公司（以下简称"公司"）于 2023 年 7 月 21 日 在指定信息披露媒体上发布了《关于法院裁定受理公司重整并指定管理人暨公司 股票交易将被叠加实施退市风险警示的公告》（公告编号：2023-103），公司股 票交易于 2023 年 7 月 21 日被叠加实施退市风险警示。若公司出现《深圳证券交 易所股票上市规则》（以下简称"《上市规则》"）第 9.4.17 条第（六）项规定 的情形，公司股票将面临被终止上市的风险。 2、《上市规则》第 9.4.10 条规定："上市公司股票交易因本节规定被实施 退市风险警示期间，应当至少每五个交易日披露一次公司股票可能被终止上市 的风险提示公告，直至相应情形消除或者本所终止其股票上市。" ...

二、累计对外担保数量及逾期担保的数量 截至本公告披露日，公司及控股子公司担保总额度为 1,200,000 万元（被担 保单位均为合并报表范围内公司，担保额度均经公司股东大会审议并授权），占 2022 年经审计总资产的比例为 51.15%；占 2022 年经审计净资产的比例为 -137.45%。 | 证券代码：002157 | 证券简称：*ST 正邦 | 公告编号：2023—130 | | --- | --- | --- | | 转债代码：128114 | 转债简称：正邦转债 | | 江西正邦科技股份有限公司 关于为下属子公司担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 江西正邦科技股份有限公司（以下简称"公司"或"正邦科技"）于 2022 年 12 月 26 日召开第七届董事会第六次会议，审议通过了《关于 2023 年度对外担 保额度预计的议案》，为保证公司及控股子公司日常生产经营，公司拟为合并报 表范围内子公司提供担保、控股子公司之间互相担保，担保额度总计不超过 1,200,000 万元（该预计担保额度可循环使用）；其中本公司或控股子公司为 ...

股票代码：002157 股票简称：*ST正邦 债券代码：128114 债券简称：正邦转债 江西正邦科技股份有公司 公开发行可转换公司债券 第三次临时受托管理事务报告 （2023年度） 债券受托管理人 二〇二三年八月 重要声明 本报告依据《公司债券发行与交易管理办法》（以下简称"《管理办法》"）、 《江西正邦科技股份有限公司公开发行可转换公司债券之债券受托管理协议》（以 下简称"《受托管理协议》"）、《江西正邦科技股份有限公司公开发行可转换公 司债券募集说明书》（以下简称"《募集说明书》"）等相关公开信息披露文件， 由本期债券受托管理人国信证券股份有限公司编制。国信证券对本报告中所包含的 从上述文件中引述内容和信息未进行独立验证，也不就该等引述内容和信息的真实 性、准确性和完整性做出任何保证或承担任何责任。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关事 宜做出独立判断，而不应将本报告中的任何内容据以作为国信证券所作的承诺或声明。 在任何情况下，投资者依据本报告所进行的任何作为或不作为，国信证券不承担 任何责任。 国信证券股份有限公司（以下简称"国信证券"）作为江西正邦科技股份有限公 司（ ...

| 证券代码：002157 | 证券简称：*ST正邦 | 公告编号：2023—129 | | --- | --- | --- | | 转债代码：128114 | 转债简称：正邦转债 | | 江西正邦科技股份有限公司 关于2023年7月份生猪销售情况简报 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 江西正邦科技股份有限公司（以下简称"公司"）的经营范围中包括生猪养 殖业务，现公司就每月生猪销售情况进行披露，具体内容如下： 一、2023年7月份生猪销售情况 公司2023年7月销售生猪32.52万头（其中仔猪17.01万头，商品猪15.51万头）， 环比上升18.10%，同比下降63.15%；销售收入3.21亿元，环比上升4.57%，同比下 降56.76%。 商品猪（扣除仔猪后）销售均价13.71元/公斤，较上月下降0.30%；均重122.82 公斤/头，较上月下降0.22%。 2023年1-7月，公司累计销售生猪331.43万头，同比下降42.14%；累计销售收 入31.87亿元，同比下降43.63%。 上述数据均未经审计，与定期报告披露的数据之间可能存在差异 ...

证券代码：002157 证券简称：*ST 正邦 公告编号：2023—127 转债代码：128114 转债简称：正邦转债 2023 年 8 月 7 日至 2023 年 8 月 18 日收市前，持有"正邦转债"的投资者 仍可进行转股，2023 年 8 月 18 日的次一交易日（即 2023 年 8 月 21 日）起，债 券持有人不再享有转股的权利。 2、2023 年 8 月 18 日收市后，仍未转股的"正邦转债"持有人可基于依法 享有的债权进行债权申报，债权类型为无财产担保普通债权。根据《江西正邦 科技股份有限公司重整计划（草案）》（以下简称"《重整计划草案》"）中 普通债权的清偿方案，每家持有"正邦转债"的债权人 10 万元以下部分（含 10 万元）以现金形式全额清偿。债权总额为人民币 2000 万元以下（含 2000 万元） 的，超过 10 万元的部分，以正邦科技转增股票清偿，每 100 元普通债权可获得 约 8 至 9.09 股转增股票，抵债价格为 11 元/股至 12.5 元/股；债权总额为 2000 万元以上的，超过 10 万元的部分，以信托受益权份额及正邦科技转增股票抵债 的方式清偿，每 100 元普 ...

| 证券代码：002157 | 证券简称：*ST 正邦 | 公告编号：2023-126 | | --- | --- | --- | | 转债代码：128114 | 转债简称：正邦转债 | | 江西正邦科技股份有限公司 关于股票交易异常波动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 针对公司股票交易异常波动，公司对有关事项进行了核查，并发函征询了公 司控股股东及实际控制人，现就有关情况说明如下： （一）公司前期披露的信息不存在需要更正、补充之处。 （二）公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产 生较大影响的未公开重大信息。 （三）近期公司经营情况及内外部经营环境未发生重大变化。 （四）经自查和函询，公司、控股股东和实际控制人不存在关于公司应披露 而未披露的重大事项。 1、2023年7月20日，公司收到江西省南昌市中级人民法院（以下简称"南昌 中院"）送达的（2022）赣01破申49号《民事裁定书》，南昌中院裁定受理锦州 天利粮贸有限公司对公司的重整申请。同日，公司收到南昌中院送达的（2023） 赣01破16号《决定书》， ...

证券代码：002157 证券简称：*ST 正邦 江西正邦科技股份有限公司 编号：20230518 | | 特定对象调研 | □分析师会议 | | --- | --- | --- | | 投资者关系活动 类别 | □媒体采访 | √业绩说明会 | | | □新闻发布会 | □路演活动 | | | □现场参观 | | | | □其他 | | | 参与单位名称及 | 线上参与正邦科技 2022 | 年度网上业绩说明会的投资者 | | 人员姓名 | | | | 时间 | 2023 年 05 月 18 | 日（星期四）下午 16:00-17:00 | | 地点 | 价值在线（www.ir-online.cn） | | | 上市公司接待人 | 董事长兼总经理：林峰先生 | | | | 独立董事：曹小秋先生 | | | | 持续督导保荐代表人：付爱春先生 | | | 员姓名 | 财务总监：王永红先生 | | | | 董事会秘书：祝建霞女士 | | 问：1.公司面对目前的困境吸取到哪些深刻教训以及未来 5 年的发展规划？2. 目前重整情况如何？ 答：您好，1、公司从原先高速扩张发展转为注重经营质量及稳健的发展策略。 今年总 ...

一、说明会召开的时间、地点和方式 会议召开时间：2023 年 05 月 18 日（星期四）16:00-17:00 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络互动方式 重要内容提示： 江西正邦科技股份有限公司（以下简称"公司"）已于 2023 年 4 月 29 日在巨 潮资讯网上披露了《2022 年年度报告全文》及《2022 年年度报告摘要》。为便 于广大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定于 2023 年 05 月 18 日（星期四）16:00-17:00 在"价值在线"（www.ir-online.cn）举 办江西正邦科技股份有限公司 2022 年度网上业绩说明会，与投资者进行沟通和 交流，广泛听取投资者的意见和建议。 会议召开时间：2023 年 05 月 18 日（星期四）16:00-17:00 会议召开方式：网络互动方式 会议召开地点：价值在线（www.ir-online.cn） 会 议 问 题 征集 ： 投 资者 可 于 2023 年 05 月 18 日 前访 问 网 址 https://eseb.cn/13RIRrEGpr2 或使用微信扫描 ...

Financial Performance - Revenue in 2022 decreased by 69.76% to RMB 14,415,038,850.39 compared to 2021[15] - Net profit attributable to shareholders in 2022 improved by 28.86% to a loss of RMB 13,387,147,012.44[15] - Total assets decreased by 49.62% to RMB 23,459,107,708.73 at the end of 2022[15] - Net cash flow from operating activities in 2022 worsened by 148.04% to a negative RMB 5,467,628,075.78[15] - Basic earnings per share in 2022 improved by 28.68% to a loss of RMB 4.2833[15] - Weighted average return on equity in 2022 improved by 3,646.11% to a negative 421.47%[15] - Revenue in Q4 2022 was RMB 1,039,525,306.47, the lowest among all quarters[20] - Net loss attributable to shareholders in Q4 2022 was RMB 5,743,252,897.12, the highest among all quarters[20] - Non-operating income and expenses in 2022 resulted in a loss of RMB 137,541,903.46[22] - Company's total operating revenue for the reporting period was 14.415 billion yuan, a year-on-year decrease of 69.76%[36] - Net profit attributable to shareholders of the listed company was -13.387 billion yuan, with a year-on-year narrowing of losses by 28.86%[36] - Sales revenue from the veterinary drug business was 101 million yuan, a year-on-year decrease of 45.75%[36] - Sales revenue from the pig farming business was 8.597 billion yuan, a year-on-year decrease of 70.31%[36] - Feed business revenue was 5.677 billion yuan, accounting for 39.38% of total operating revenue, a year-on-year decrease of 65.55%[39] - Pig farming business revenue was 8.597 billion yuan, accounting for 59.64% of total operating revenue, a year-on-year decrease of 70.31%[39] - Veterinary drug business revenue was 101 million yuan, accounting for 0.70% of total operating revenue, a year-on-year decrease of 45.75%[39] - Revenue from the southern region was 8.526 billion yuan, accounting for 59.15% of total operating revenue, a year-on-year decrease of 67.12%[40] - Revenue from the northern region was 1.356 billion yuan, accounting for 9.40% of total operating revenue, a year-on-year decrease of 86.70%[40] - Revenue from the southwestern region was 4.494 billion yuan, accounting for 31.17% of total operating revenue, a year-on-year decrease of 60.74%[40] - The company's breeding business revenue decreased by 70.31% year-on-year to 8,597,247,314.96 yuan, with a gross margin of -48.08%[41] - The feed business revenue dropped by 65.55% year-on-year to 5,677,036,069.41 yuan, with a gross margin of 2.09%[41] - The breeding business accounted for 69.24% of the total operating costs, amounting to 12,730,837,065.66 yuan, a decrease of 69.86% year-on-year[43] - The feed business accounted for 30.23% of the total operating costs, amounting to 5,558,142,253.32 yuan, a decrease of 63.98% year-on-year[43] - The top five customers contributed 7.98% of the total annual sales, amounting to 1,150,610,397.36 yuan[47] - The top five suppliers accounted for 8.61% of the total annual procurement, amounting to 1,144,199,734.29 yuan[48] - Sales expenses decreased by 54.59% year-on-year to 170,400,343.10 yuan due to company downsizing[50] - Management expenses decreased by 19.17% year-on-year to 2,939,093,123.23 yuan due to company downsizing[50] - R&D expenses dropped by 95.21% year-on-year to 26,132,381.23 yuan due to reduced R&D investment[50] - R&D personnel decreased by 92.90% from 1,098 in 2021 to 78 in 2022[51] - R&D investment dropped by 95.21% from 545,882,371.06 yuan in 2021 to 26,132,381.23 yuan in 2022[51] - R&D investment as a percentage of revenue decreased from 1.15% in 2021 to 0.18% in 2022[51] - Net cash flow from operating activities decreased by 148.04% from -2,204,291,113.41 yuan in 2021 to -5,467,628,075.78 yuan in 2022[53] - Net cash flow from financing activities increased by 166.02% from -6,655,024,596.71 yuan in 2021 to 4,393,711,875.32 yuan in 2022[54] - Total investment in the reporting period decreased by 94.52% from 28,224,351,700.00 yuan in the previous year to 1,545,400,000.00 yuan[58] - Cash and cash equivalents decreased by 84.58% from -9,893,512,333.84 yuan in 2021 to -1,525,790,864.33 yuan in 2022[53] - Fixed assets accounted for 45.88% of total assets in 2022, up from 35.34% in 2021[56] - Short-term loans increased by 24.42% to 12,704,455,992.00 yuan in 2022, accounting for 54.16% of total assets[56] - Inventory decreased by 5.68% to 2,360,273,080.69 yuan in 2022, down from 7,329,308,698.11 yuan in 2021[56] - The company reported a net loss of 1,434,585.19 million yuan for 2022[180] - As of December 31, 2022, the net assets attributable to the parent company were -873,057.59 million yuan[180] Business Operations - The company focuses on pig farming, with feed and veterinary drug businesses supporting the main business[30] - Feed business production and sales were significantly impacted in the first half of 2022 due to domestic hog price fluctuations and stricter breeding policies, leading to a gradual shutdown of domestic feed mills in the second half to alleviate financial pressure[33] - The company's hog breeding business faced performance pressure in 2021 due to rapid capacity release coinciding with low domestic hog prices, prompting strategic adjustments to focus on high-quality development[35] - The company retained its core breeding population and improved breeding efficiency, with GGP sows achieving an average of 14.0 live births for Large White and 13.5 for Landrace, and Duroc reaching 100 kg in 145 days[34] - The company streamlined its organizational structure by eliminating secondary management centers, reducing management layers to three levels: headquarters, regions, and farms/service departments, to enhance operational efficiency[35] - The company introduced intelligent breeding systems through its Digital Livestock Research Institute, achieving cost reduction and efficiency improvement, with plans to launch the next-generation intelligent pig house version 3.0 in 2023[35] - The company disposed of idle and inefficient assets to improve capacity utilization and cash flow, optimizing overall asset quality and enhancing capital efficiency[35] - The company focused on internal management and regional optimization to accelerate business transformation, aiming to improve operational efficiency and stabilize core production[35] - The company's "company + farmer" model expanded hog breeding capacity by leveraging farmers' fixed assets and land resources, while the company provided piglets, feed, and technical support, bearing market risks[32] - The company's veterinary drug business utilized a first-tier agent distribution model and established a breeding technology training academy to provide specialized training for large-scale pig farms[32] - The company's feed business adopted a combination of dealer, direct sales, and pig farm co-management models to enhance product value and customer loyalty in the first half of 2022[32] - The company will focus on pig farming as its core business, transforming feed and veterinary sectors into supporting roles[80] - Efforts to reduce breeding costs and enhance core competitiveness through organizational optimization and digital transformation[81] - The company has established a specialized African swine fever prevention and control management team and developed a biosecurity prevention and control management system[85] - The company has optimized its organizational structure to establish a three-tier management hierarchy for the breeding business, enhancing management efficiency and reducing production costs[86] - The company has implemented a hierarchical management system for decentralized operations, using information technology to achieve online office work in various aspects of business management[86] - The company sets reasonable pig repurchase prices based on market forecasts and cost control to ensure reasonable profits for farmers and reduce market risks[86] - The company maintains complete independence in business, personnel, assets, organization, and finance from its controlling shareholder, ensuring autonomous operations[91] - The company has obtained over 40 national patent authorizations and won 1 provincial-level first prize for scientific and technological progress[160] - The company has developed management and sales platform tools such as "Bangnong Cloud," "Bang Marketing," "Bang Yangbao," and "Bang Fanbao" to ensure product quality traceability and improve management efficiency[159] - The company has implemented two types of pig farm sewage treatment processes: one based on integrated farming and the other on compliant discharge standards[160] - The company has established a full-process traceable food safety system to enhance product quality and control management details[159] - The company has focused on technological innovation in areas such as pig breeding, feed nutrition, disease prevention, and automation in livestock engineering[160] - The company has actively engaged in industrial poverty alleviation and rural revitalization, promoting the "company +贫困户" pig farming model[162] - The company has strengthened internal supervision and compliance, issuing the "Eight Prohibitions on Integrity and Self-Discipline" to ensure efficient and clean operations[159] - The company has optimized its industrial structure to reduce consumption and increase efficiency, transitioning from traditional agriculture to modern, intelligent, and high-return agriculture[159] - The company has formed a green ecological cycle chain through integrated farming, transforming barren land into fertile agricultural land[160] - The company has established a dedicated environmental protection department to design pig farm environmental solutions and reduce environmental costs[159] Risks and Uncertainties - The company faces significant uncertainties in its restructuring process, including risks related to swine diseases, food safety, natural disasters, and fluctuations in hog and pork prices[3] - The company has issued a risk warning regarding its convertible bonds, highlighting potential risks such as interest rate risk, liquidity risk, and credit risk[4] - The company's financial statements for 2022 were audited by Da Hua Certified Public Accountants, which issued an unqualified audit opinion with an emphasis on material uncertainty regarding the company's ability to continue as a going concern[2] - The company is required to comply with the disclosure requirements for the livestock and aquaculture industry as per the Shenzhen Stock Exchange's self-regulatory guidelines[2] - The company faces significant uncertainty in its restructuring process, with potential risks of bankruptcy and delisting[81] - Risks from swine diseases, such as African swine fever, could significantly impact production costs and market supply[81] - Food safety risks could affect the company's brand and profitability if issues arise[82] - Natural disasters could damage facilities and reduce pig inventory, impacting operations[83] - Fluctuations in pig and pork prices pose risks to the company's profitability due to market volatility[83] - Risks associated with leasing rural land for farming operations could disrupt production if leases are not renewed[83] - The company has unfulfilled convertible bonds amounting to 1,317.1 million yuan, with potential repayment risks[83] - The company faces risks in the self-breeding model, including remote management risks and funding risks due to the high capital requirements for rapid expansion of pig farming scale[84] - The company mitigates moral risks in the "company + farmer" cooperative breeding model through contract constraints, comprehensive technical services, and real-time monitoring using pig farm management software[84] - The company's audited net assets at the end of 2022 were negative, leading to a delisting risk warning and a one-day trading suspension starting May 4, 2023[186] - The company was subject to pre-reorganization proceedings initiated by creditors, with multiple announcements made on the progress and meetings from October 2022 to April 2023[187][188][189] - The company's subsidiaries and related parties were involved in bankruptcy reorganization, with court rulings and creditor meetings held from October 2022 to February 2023[188][189] - The company's controlling shareholders and their affiliates were also subject to bankruptcy reorganization, with court rulings and creditor meetings held from October 2022 to February 2023[188][189] - The company faced significant litigation and arbitration cases, with total claims amounting to 83,137.29 thousand RMB as the plaintiff and 362,048.73 thousand RMB as the defendant[190] - The company has recognized a liability of 28,923.5 thousand RMB based on accounting standards and actual circumstances related to the litigation and arbitration cases[190] - The company's controlling shareholder, Zhengbang Group, and its affiliated company, Jiangxi Yonglian Agricultural Holding, were issued a warning letter by the China Securities Regulatory Commission for failing to disclose a pre-disclosure announcement 15 trading days in advance and for exceeding the proportion of share reduction[191] - Jiangxi Zhengbang Technology Co., Ltd. received a warning letter from the China Securities Regulatory Commission for failing to return raised funds on time[192] - As of January 31, 2023, the recognized creditor claims for the restructuring of Zhengbang Group and Jiangxi Yonglian Agricultural Holding amounted to RMB 22,210,571,833.31, with an additional RMB 10,851,743,242.23 still under review[193] Investments and Fundraising - The company invested RMB 310 million in Yibin Guanglian Breeding Co., Ltd., acquiring a 100% stake[59] - The company invested RMB 465 million in Hunan Linwu Zhengbang Breeding Co., Ltd., acquiring a 100% stake[59] - The company invested RMB 180 million in Peng'an Zhengbang Agriculture and Animal Husbandry Co., Ltd., acquiring a 100% stake[60] - Total investment in the three companies amounted to RMB 955 million[60] - All investments were completed as of the balance sheet date[59][60] - The investments were funded by the company's subsidiaries' receivables[59][60] - No expected returns or investment gains/losses were reported for the investments[59][60] - The investments were disclosed on June 1, 2022, through major financial newspapers and the company's website[59][60] - The company did not engage in any securities or derivative investments during the reporting period[61] - The company's fundraising usage was applicable but specific details were not provided[62] - Total raised funds amount to RMB 1,061,880.43 million, with RMB 677,847.02 million already utilized[63] - In 2020, RMB 160,000 million was raised through convertible bonds, with RMB 45,674.84 million utilized and RMB 112,436.58 million changed in purpose[63] - In 2020, RMB 750,000 million was raised through non-public A-share issuance, with RMB 498,692.74 million utilized and RMB 249,366 million changed in purpose[63] - Cumulative change in purpose of raised funds amounts to RMB 361,802.58 million, representing 34.07% of total raised funds[63] - In 2018, RMB 99,274.49 million was raised through non-public A-share issuance, with RMB 80,873.5 million utilized[63] - In 2017, RMB 52,605.94 million was raised through public corporate bonds, fully utilized by the end of 2017[63] - Unused raised funds amount to RMB 2,222.6 million, stored in special accounts for raised funds[63] - In 2021, RMB 17,054.17 million of surplus raised funds was permanently used to supplement working capital[63] - In 2020, RMB 121,500 million of idle raised funds was temporarily used to supplement working capital, fully returned by June 30, 2021[63] - In 2021, RMB 113,000 million of idle raised funds was temporarily used to supplement working capital, with RMB 2,760 million returned by December 31, 2021[63] - The company postponed the repayment of RMB 1.1024 billion from the 2019 public issuance of convertible bonds and continued to use it for temporary working capital, with a delay of up to 12 months[64] - The company permanently supplemented working capital with RMB 1.1239 billion from the remaining funds of a terminated fundraising project as of December 31, 2022[64] - The cumulative investment in fundraising projects reached RMB 4.9869 billion as of December 31, 2022, with RMB 3 billion used from December 30, 2020, to December 31, 2020[64] - The company used RMB 1.824 billion of fundraising funds in 2021 and RMB 9.6088 million in 2022[64] - The company postponed the repayment of RMB 2.44 billion from the 2020 private placement fundraising and continued to use it for temporary working capital, with a delay of up to 12 months[64] - The company permanently supplemented working capital with RMB 2.472 billion from the remaining funds of a terminated fundraising project as of December 31, 2022[64] - The investment progress for the "Breeding and Farming Combined" base project in Guyu Village, Lieshan District, reached 76.79% as of the reporting period[65] - The investment progress for the "Breeding and Farming Combined" base project in Yucheng reached 46.48% as of the reporting period[65] - The investment progress for the "Breeding and Farming Combined" base project in Panji reached 34.29% as of the reporting period[66] - The investment progress for the Long'an Zhenyi Ecological Breeding Base project in Guangxi reached 15.28% as of the reporting period[66] - Total investment in committed projects

Financial Performance - The company's operating revenue for Q1 2023 was ¥2,255,605,183.13, a decrease of 65.24% compared to the same period last year[2] - The net profit attributable to shareholders was -¥1,178,637,052.52, representing an improvement of 51.56% year-over-year[2] - Total revenue for Q1 2023 was CNY 2,255,605,183.13, a significant decrease from CNY 6,489,838,002.48 in the same period last year, representing a decline of approximately 65.2%[16] - The company reported a net loss attributable to shareholders of CNY -9,921,449,533.87 for Q1 2023, compared to a loss of CNY -8,730,575,914.92 in the previous year[15] - The net profit for Q1 2023 was -1,268,721,336.15 CNY, compared to -2,663,778,564.34 CNY in Q1 2022, showing an improvement of approximately 52.4% year-over-year[17] - Operating profit for Q1 2023 was -1,219,399,592.01 CNY, a decrease from -2,541,164,560.40 CNY in the same period last year, indicating a 52.0% reduction in losses[17] - The total comprehensive income for Q1 2023 was -1,289,011,260.94 CNY, compared to -2,680,905,072.03 CNY in the same quarter last year, indicating a 52.0% reduction in comprehensive losses[17] Cash Flow and Assets - The net cash flow from operating activities improved by 78.96%, amounting to -¥286,348,393.13, due to reduced operational inputs[5] - Cash and cash equivalents at the end of Q1 2023 amounted to CNY 836,103,402.62, an increase from CNY 783,797,683.11 at the beginning of the year[14] - Cash flow from operating activities showed a net outflow of -286,348,393.13 CNY, an improvement from -1,360,823,060.19 CNY in the previous year[18] - Cash and cash equivalents at the end of Q1 2023 totaled 466,222,994.73 CNY, compared to 706,202,491.19 CNY at the end of Q1 2022, reflecting a decrease of about 33.9%[19] - Total assets at the end of the reporting period were ¥22,193,350,249.89, down 5.40% from the previous year[2] - Total assets decreased to CNY 22,193,350,249.89 from CNY 23,459,107,708.73, indicating a decline of approximately 5.4%[15] Expenses and Cost Management - Research and development expenses were reduced by 100%, indicating a halt in R&D investments due to the company's scale-down[5] - The company reported a significant decrease in sales expenses by 83.32%, reflecting the overall contraction in its business operations[5] - Total operating costs for Q1 2023 were CNY 3,481,201,564.84, down from CNY 8,586,392,666.46 year-over-year, indicating a reduction of about 59.5%[16] - The company incurred operating expenses of 2,510,354,581.07 CNY in Q1 2023, compared to 10,670,661,628.92 CNY in the previous year, indicating a decrease of about 76.5%[18] - The company plans to focus on cost reduction and efficiency improvements in response to the significant decline in revenue and profitability[16] Shareholder and Equity Information - The company's total equity attributable to shareholders decreased by 13.64% to -¥9,921,449,533.87[2] - The number of ordinary shareholders at the end of the reporting period was 194,404, with the largest shareholder, Zhengbang Group Co., Ltd., holding 21.80% of the shares[6] - The company’s total equity attributable to shareholders was CNY -9,921,449,533.87, compared to CNY -8,730,575,914.92 in the previous year, reflecting a worsening of approximately 13.6%[15] Restructuring and Corporate Actions - The company has been actively engaging in restructuring efforts to address financial challenges[8] - The company received a court decision extending the pre-restructuring period until April 22, 2023[8] - The first temporary creditors' meeting for the company's pre-restructuring was held on February 10, 2023[9] - The company adjusted the conversion price of its convertible bonds to RMB 3.62 per share effective March 9, 2023[10] - The company's credit rating was downgraded to B with a negative outlook as of February 28, 2023[10] - The controlling shareholder and its concerted parties completed their share reduction plan, reducing a total of 32,714,383 shares[10] - The first temporary creditors' meeting for the substantial merger restructuring of the controlling shareholder was held on February 9, 2023[9] - The company disclosed the results of the first temporary creditors' meeting for its subsidiary's substantial merger restructuring on February 22, 2023[9] - The company received notifications regarding the progress of the substantial merger restructuring for its subsidiaries on multiple occasions in early 2023[9] - The controlling shareholder's share reduction plan was completed as of February 14, 2023[12]